The Record

The Hooman Asbaghi Case

File 01

The Company

Padtan Elm was a real company. Kits were sold. A 1999 power of attorney names Farideh Kavesh as his attorney. After that date, his name on company paper is read as her using that instrument — not as proof he was in the room, and not as proof he was paid. He says he received nothing. Even if a 2013 share deed cannot be shown, the claim is that he was excluded from control and proceeds. That question is now before the court in Asbaghi vs Asbaghi.

Founding general meeting

Founding general meeting

Date line on this photo is blank

1999 power of attorney

1999 power of attorney

Office 198 · full first page, not the tight zoom

Behlouli letter

Behlouli letter

Farsi original, 14 Jan 2013 as printed in the letter

Directory listing — MD: Narges Javad

Directory listing — MD: Narges Javad

Plaque 50, South Sarparast. Phones held off this caption

iranindustry.de — manager Narges Javad

iranindustry.de — manager Narges Javad

PADTAN ELM CO. / Lab Kit. Independent of Docs6

Related-name marks as he presented them

Related-name marks as he presented them

Elm, Padza, Danesh, Pishtaz Teb. Name-family, not a register

Named kits · warehouse inserts

Neonatal G6PD

Neonatal G6PD

96-test enzymatic kit

H. pylori IgA

H. pylori IgA

EIA kit under the Padtan Elm mark

AFP EIA

AFP EIA

Quantitative AFP insert

Ferritin EIA

Ferritin EIA

Company mark on the insert

This is the company file. The 1999 power of attorney and the 2013 inspector letter sit in their own sections. Independent reporting on this dispute is linked from the home page; it is coverage, not an exhibit. Roche dollar figures stay off this site until source contract pages exist. Continue in the 1999 power of attorney and the 2013 letter.

After 1999, Hooman’s name on Padtan paper is treated as Farideh using that power of attorney unless a document independently shows his own hand and presence. July 2003 minutes already print his holding “by power of attorney of Farideh.” A 2016 gazette that names him vice-chair, and 2018 and 2022 lists that still print 250 shares, are the same structure. They are not proof he sat in the room. They are not proof he was paid. His claim is that he received nothing from the company. Name-on-paper is not a dividend.

The live theory is exclusion from control and proceeds, not only a missing deed. An attorney-in-fact has a duty to act in the principal’s interest. That is the legal frame of the civil case. It is not a closing that “she stole the company.” The 14 January 2013 share-transfer instrument has not been mounted. If concealment is the theory, the people who would have held that paper would not publish it. Absence of the deed is therefore expected on that theory. It is not, by itself, proof of a conspiracy. What is on paper that day is an official gazette adding “export of all permitted goods” to the company’s objects — same calendar date, different act.

Kianoosh Behlouli’s Farsi letter is the witness document for that week. Rasmio and warehouse minutes put him in the inspector’s seat for 2011–2013, as alternate inspector, with Amargaran Accounting as principal. The letter’s own heading says principal. Keep both. The match of man, office, and years is why the letter is treated as more than anonymous commentary. It is still not a court finding.

He named Narges Javad as a co-founder when the investigator met him. His recall of other events from that period has been good. Keep the claim. The 1996 founding minutes still do not print her — four names, including Mostafa Bagherzadeh. What the warehouse and public record do print: equal shareholder by October 2002; managing director on the May 2012 gazette; manager / MD on public directories, one of them at plaque 50, the founding-board address. That is a principal. It is not a rewrite of Docs6.

The May 2012 recapitalization is the other scale that belongs here. Paper capital moved from 62.5 million rials to 6 billion, paid by conversion of matured claims. Iran ran two dollar rates that year. After 28 January 2012 the Central Bank official rate was 12,260 rials to the dollar. At that official scale the jump is about $5,100 to about $489,000. On the parallel-market year average it is about $2,400 to about $230,000. That is hundreds of thousands of dollars of paper capital, not a documented USD wire, and the gazette does not name who held the claims.

The Palmaz-Schatz calendar is supporting context, not a shipping record. First coronary implant December 1987; international coronary use underway by 1991; U.S. iliac approval 1991; U.S. coronary approval August 1994. That U.S. date does not close an early-1990s introduction in Tehran. Hospital histories date angioplasty expansion there to 1370 SH (March 1991–March 1992). Foreign proctors for new devices were ordinary. None of those pages currently print his name on a crate or an itinerary.

Two years before that 2013 export-clause gazette, the Farci Rasmio dump of the same company — register 127180, national ID 10101705792 — prints a unique gazette the English extract did not table. Extraordinary meeting dated 8/3/90 (~29 May 2011); gazette printed 1391/03/08; news 11777168. Objects as printed: production of laboratory and hospital medical-diagnostic goods; import of primary materials, equipment, and machinery needed for production; research into production of medical diagnostic kits. Kit production and import of production inputs were already on the register. That is not the missing share deed.

The 2013 calendar is kept in that same spirit. On 14 January the gazette adds “export of all permitted goods” to Padtan Elm’s objects. On 23 June, padtanteb.ir has its first listed Wayback save. On 1 July, Executive Order 13645 / IFCA takes effect. Those dates are real. The order is sectoral — energy, shipping, shipbuilding, the rial, the auto sector — and broader U.S. Iran sanctions already existed. It is not a finding that kit exports became newly illegal that morning, and it is not a finding that anyone created a shell to evade. The open question is narrower: an old registered IVD company with a long gazette trail is a harder name for a counterparty to take than a clean new entity. Padtan Teb’s own copy claims 1366, 1369, and 1990. Those years are not the same. A new website is not a new legal entity. The entire warehouse Padtan Teb folder was listed: an introduction still, two kit stills, and a titled report. There is no company-register page with a national ID, a register number, and an official founding date. Website years are not the register. Keep the conflict and move on.

Ghasemi’s own CV independently prints a Scripps Clinic endovascular certificate in 2003 and lists M. Saeed and Paul Teirstein as Scripps references — the same campus and the same names that appear in the claim he was brought to San Diego around 2000/2003. Those lines are printed as a certificate and as references. They are not a 1990s training log, and they are not proof Hooman made the introduction. Folder 3 and a warehouse title search found no boarding pass, Scripps badge, or letter that he arranged that trip. The CV already matches year and campus. The introduction is still the claim. Mohsin Saeed is pinned for later.

The rest of the folder titled Articles Naming Padtan ELM is now walked. A Wiley methods block names Padtan Elm of Tehran on the same chemicals page as SinaClon of Tehran. A colonoscopy paper prints “Padtan elm kit (made in Iran) was used to measure PSA.” A companion education paper measures hemoglobin and ferritin “using Padtan Elm Company (Iran).” The second PDF of the IgE paper is the same 1.88 MB file already on this page — not a second citation. An Elsevier bookstore search for “Alnylam AND Padtan Elm” that returns 45,200 unrelated books is a search hit. It is not a paper.

In November 2018 a Padtan Elm contract still names Farideh Kavesh and Soudabeh Keykavousi as authorized board members to buy 30,000 ELISA plates — Biomat Italy, catalog MGOIF-HB8 — through Parsian Zist Idea. Register 127180 and national ID 10101705792 on that paper match the company already on this site. Euro totals stay off this page. That is hard commercial activity after the alleged 2013 exclusion. It is not the missing deed, and it is not a finding about his hips.

He presented four Google stills — Padtan Elm, Padza Padtan Pajooh, PadTan Danesh, and Pishtaz Teb — as shells of the original company. The stills show related names and similar badge logos. That is on the paper he brought. It is not a register that they are one legal entity, and it is not a finding that anyone created a shell to evade. Pishtaz Teb is already a named defendant on the 2017 Tehran filing. Padza dates itself to 2017; a public CV names Fatemeh Rabbani as its founder. A sibling iranindustry.de page prints Padtan Darou next to Padtan Elm, with Narges as manager of Padtan Elm and Asadizade as manager of Padtan Darou. SuperGrok commentary is not a gazette. The Padtan Teb subfolder still has no national-ID / register-number / official-founding-date page. Website years are not the register.

Iranome is a public genomic catalog. Its FAQ names Illumina sequencers. No page in that file names Padtan Elm, Farideh, or Hooman. A documented ELISA-kit company in the same country is capability. It is not ownership of that catalog. A Thermo Fisher search for “Padtan Elm” hits a baker’s-yeast gene called Elm1 — a string collision, not a contract. An Academia.edu title using both names existed long enough to be captured. It is not his paper. It was found by the investigator and later disappeared. Keep the anomaly.

DocumentedMay 1987 – Aug 1994
Palmaz-Schatz calendar — an early-1990s introduction was possible

Julio Palmaz’s own account: first human iliac implant May 1987, Freiburg; first coronary implant December 1987, São Paulo, with Richard Schatz and Eduardo Sousa. Johnson & Johnson licensed the project in 1986 and formed Johnson & Johnson Interventional Systems. Palmaz writes that by the 1991 U.S. iliac approval, coronary experience already existed in Rotterdam, Kokura, Mainz, Nancy, Milan, Madrid, Buenos Aires, and elsewhere. U.S. iliac (peripheral) approval 1991; U.S. coronary PMA P900043, 2 August 1994, after BENESTENT and STRESS. A December 1993 FDA panel had refused coronary approval without a randomised trial. His account of Iran work in 1991–93 therefore sits after first-in-human use and during documented international coronary use — not after U.S. commercial approval.

Establishes. The device was in human coronaries from 1987 and in international clinical use in the early 1990s. U.S. coronary approval in 1994 does not bar use outside the United States in 1991–93. Tehran hospital histories date an expansion of angioplasty to 1370 SH (March 1991–March 1992). Foreign proctors for new devices were ordinary in that era.

Does not establish. Does not name Hooman, Valeix, Ghasemi, or Imam Khomeini Hospital on a shipment, itinerary, or operative log. Valeix’s 1992–93 papers describe the Wiktor stent, a different device. Angioplasty arriving in Tehran is not the same sentence as Palmaz-Schatz arriving in his hands. The calendar makes the activity possible. It does not prove he was the person who did it.

Facts

Source: Public: Palmaz EuroIntervention; FDA PMA P900043 / Federal Register 10 Jul 1997

Padtan Elm LLC constitution — four founders
Documented8 Sep 1996 (1375/06/18)
Padtan Elm LLC constitution — four founders

Founding general-meeting minutes. Date and hour lines on this photo are blank. CamScanner footer cropped. Four signatures at the foot.

Four partners × 25%: Mostafa Bagherzadeh, Alireza Amiri Gharagozlou, Farideh Kavesh, Hooman. Capital 50 million rials. Narges is not on this founding page. Companion warehouse pages: first board minutes (Docs3) name Alireza chair and Farideh managing director at plaque 50, date and hour blank; constitution last page (Docs14) is dated 1375/6/18 and signed by the same four. Official register date on Rasmio is 1375/10/17.

Establishes. The company was formed on paper with those four names. LinkedIn’s 1995 line is marketing copy. The constitution date on the scan is 8 September 1996.

Does not establish. Does not prove later share movements, a 2013 transfer, or that memos listing Narges as a 1995 founder are correct. Originals beat memos.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs6.jpeg

Documented8 Sep 1996 (1375/06/18 companion; date line blank)
First LLC board — Alireza chair, Farideh managing director

First board meeting of Padtan Elm LLC at plaque 50, Taleghani / Keyvan. Present: Farideh Kavesh, Seyed Hooman Ali Tabatabaei Asbaghi, Dr Alireza Amiri Gharagozlou, Dr Mostafa Bagherzadeh. Capital 50 million rials paid in cash. Alireza named board chair; Farideh named managing director with authority to run the company. Date and hour lines on this photo are blank, as on the founding minutes.

Establishes. The opening board was those four people. Farideh was managing director from the first meeting. Narges is not on this page.

Does not establish. A blank date line is not a 1995 founding. This page does not move later shares.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs3.jpeg

Documented2002 (archive.org summary)
padtan.com Wayback captures from 2002

archive.org summary chart for www.padtan.com shows years 2002–2004 populated.

Establishes. A public web footprint for padtan.com is archived from 2002.

Does not establish. Does not prove suppression, and does not date a 2013 transfer. A later archive.org metadata search that returns no hits is not deletion of the 2002–2004 calendar already captured.

Facts

Source: Folder 3 / Wayback

Padtan Elm Neonatal G6PD kit insert
DocumentedWayback / Padtan Elm insert
Padtan Elm Neonatal G6PD kit insert

Cropped from the warehouse still. Safari chrome removed. The insert prints پادتن علم / PADTAN ELM.

Kit insert for a 96-test Neonatal G6PD enzymatic assay. Intended use, kit contents, and storage at 2–8 °C are printed under the Padtan Elm mark.

Establishes. Padtan Elm sold named diagnostic kits under its own mark.

Does not establish. A product insert does not prove a 2013 share taking, a Roche contract, or a closed loop from his hips.

Facts

Source: Folder 3 / 2. The Padtan Elm Kits / Padtan ELM Neonatal G6PD.1.jpeg

Padtan Elm Helicobacter pylori IgA kit insert
DocumentedWayback / Padtan Elm insert
Padtan Elm Helicobacter pylori IgA kit insert

Cropped from the warehouse Wayback still. WhatsApp chrome and archive.org footer removed. The insert prints پادتن علم / PADTAN ELM.

EIA kit for semi-quantitative IgA antibodies to H. pylori in serum and plasma. 96 tests. Store at 2–8 °C. Coated wells, calibrators, and HRP conjugate are listed under the company mark.

Establishes. A second named Padtan Elm diagnostic kit exists on an archived insert.

Does not establish. Does not prove a 2013 share taking, a Roche contract, or that his own labs were run on this kit.

Facts

Source: Folder 3 / 2. The Padtan Elm Kits / Padtan ELM Helicobacter Pylori IgA.1.jpeg

Padtan Elm AFP EIA kit insert
DocumentedWayback / Padtan Elm insert
Padtan Elm AFP EIA kit insert

Cropped from the warehouse Wayback still. Phone chrome and archive.org footer removed.

Quantitative AFP EIA for serum and plasma. Intended use and two-antibody sandwich method printed under the Padtan Elm mark. 96 wells.

Establishes. AFP was among the named kits sold under the Padtan Elm mark.

Does not establish. A tumor-marker insert does not prove a closed loop into his chart.

Facts

Source: Folder 3 / 2. The Padtan Elm Kits / Padtan ELM AFP EIA Kit.1.jpeg

Padtan Elm Ferritin EIA kit insert
DocumentedWayback / Padtan Elm insert
Padtan Elm Ferritin EIA kit insert

Page 2 of 2 of the warehouse still. Company mark repeats at the head of the page.

Ferritin EIA procedure, calculation, and references under the Padtan Elm mark.

Establishes. Ferritin was among the named kits.

Does not establish. Does not prove his iron studies were processed on this kit.

Facts

Source: Folder 3 / 2. The Padtan Elm Kits / Padtan ELM Ferritin EIA Kit .jpeg

Documented27 Aug 2002 (1381/6/5)
2002 board page — Hooman and Ghasemi both sign

Financial statements approved 1381/6/5. Board named: Dr Hassan Bashar; Engineer Hooman Asbaghi; Dr Massoud Ghasemi; Dr Khosrow Behlouli. Representing Madayen Hospital, Bionic company, and two heart-physician groups. Signatures sit under those names.

Establishes. In 2002 Hooman and Ghasemi are printed together on the same approved board page, with hospital and device-company representation.

Does not establish. This is not Imam Khomeini letterhead. It does not prove a 1990s stent introduction, a Palmaz-Schatz shipment, or any later share taking.

Facts

Source: Folder 2 / Ghasemi / Ghasemi Legal inquiry and Hooman and him signature on hospital / WhatsApp Image (2)

Documented16 Oct 2002 (1381/7/24)
Five equal shareholders — Narges Javad on the share list

Extraordinary general meeting of Padtan Elm. Five partners at 12.5 million rials each: Farideh Kavesh, Narges Javad, Mostafa Bagherzadeh, Alireza Amiri Gharagozlou, Hooman Ali Tabatabaei Asbaghi. A four-person board is elected without Hooman. Narges is named chair; Farideh vice-chair.

Establishes. By October 2002 Narges Javad is printed as an equal shareholder. The company on that date is five names, not the original four.

Does not establish. Does not rewrite the 1996 founding page, which does not name her. Does not prove a 2013 taking. A later equal share is not a 1995 founding.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs20.jpeg

DocumentedCV on file (people tree)
Massoud Ghasemi CV — Imam Khomeini; Scripps 2003; Valeix as a reference

Massoud Ghasemi, interventional cardiologist. Attending, Imam Khomeini Medical Center, Tehran University of Medical Sciences. Interventional-cardiology fellowship, Tehran University, 1991–1992. Certificate of interventional cardiology, France, 1993; Royal Marsden 1994; Royal Brompton & Harefield 1996. Certificate of endovascular intervention (cerebrovascular and peripheral), Scripps Clinic, California, 2003. FACC since 2018. Chairman, Iranian Society of Atherosclerosis. Printed references, as written: Dr B. Valeix (France); M. Saeed, Head, Division of Vascular Radiology, Scripps Clinic, La Jolla; Dr Paul S. Teirstein, Head, Department of Cardiology, Scripps Clinic, La Jolla. Harefield names also appear. Richard Schatz is not on that list. Those lines are references, not a 1990s trainer log.

Establishes. Ghasemi’s own CV independently prints a Scripps Clinic certificate in 2003 and independently lists M. Saeed and Paul Teirstein as Scripps references — the same campus and the same names that appear in the claim he was brought to San Diego around 2000/2003. Valeix is printed as a reference. Imam Khomeini is printed as a current post. The 1991–92 Tehran fellowship sits on the same calendar as the claimed Tehran stent years; that is overlap, not a meeting log.

Does not establish. Does not prove Hooman made the introduction, paid for the trip, or trained Ghasemi. Folder 3 and a warehouse title search found no boarding pass, Scripps badge, or letter that he arranged the 2003 trip. The Ghasemi legal-inquiry folder is 2024 notice stills, not 2003 travel paper. A 2003 Scripps certificate is not 1991–93 Palmaz-Schatz training. A listed reference is not a signed visit log to Imam Khomeini. Date of birth, home address, telephones, and email on the CV are held off this page.

Facts

Source: Folder 2 / Ghasemi / 1. Massoud Ghasemi Profile.pdf

DocumentedMeeting 8/3/90 (~29 May 2011) / gazette 8 Khordad 1391
2011 objects gazette — diagnostic-kit production and import

Farsi Rasmio dump, same national ID 10101705792 and register 127180 as the 38-page English profile. Unique gazette row the English extract did not table: official gazette printed 1391/03/08 (news 11777168 / 590820) of an extraordinary meeting dated 8/3/90. Objects as printed: production of laboratory and hospital medical-diagnostic goods; import of primary materials, equipment, and machinery needed for production; research into production of medical diagnostic kits; related constitution article amended. Later unique rows in the same dump, already compatible with mounted minutes: plaque-26 address gazette 1397/02/23; 1398 board with Soudabeh Keykavousi as managing director; 1402/09/29 Behnam Safayi Zadeh CEO. Graph links to Central Pathobiology Laboratory and Amargaran are supporting network, not a theft finding. English website-overview PDFs in the same folder remain CONTEXT.

Establishes. Two years before the 14 January 2013 export-clause gazette, company-register paper already expanded objects into kit production, import of production inputs, and diagnostic-kit research. The Farci dump is the same company as the English Rasmio profile, not a second legal entity.

Does not establish. Does not name who held shares. An objects amendment is not the missing 2013 transfer deed. Related-company graph rows are not a finding those firms were shells of Padtan Elm.

Facts

Source: Folder 3 / Rasmio Farci Profile / Padtan Elm Farci rasmio-com-company-10101705792-Direct-.pdf

DocumentedPublished paper using a Padtan Elm IgE kit
Peer-reviewed method line — IgE kit from Padtan Elm Co.

Archived PDF of a medical-journal methods block (Loghman Hakim Hospital / sulfur-mustard small-airway study). Printed sentence: measurements of laboratory data performed with commercial kits including Mg (Pars Azmoon), Ca (Darman Kave, Isfahan), and IgE (Padtan Elm co). Cut-points are printed on the same page. The same folder holds a second PDF of that paper (highlighted yellow, identical 1.88 MB bytes) and a title still of Agin 2012, IJMTFM 2(2):71–76. Same paper, not a second citation. Companion warehouse stills are other search hits and a titled Academia.edu listing; the Academia title is not treated as his paper.

Establishes. Independent published methods text names a Padtan Elm commercial IgE kit as the assay used. The company was a real kit supplier in the scientific literature, not only on its own letterhead.

Does not establish. Does not prove a 2013 share taking, a Roche contract, or that he was paid. A kit citation is not a transfer deed.

Facts

Source: Folder 3 / Articles Naming Padtan ELM / Padtan Elm Being named article.jpeg

DocumentedPublished methods still (warehouse capture)
Wiley methods — Padtan Elm named next to SinaClon

Phone still of a Wiley Online Library methods block, section 2.2 Chemicals. Printed: chemicals and reagents from Sigma (St. Louis), Fitzgerald (GA), Bio-Rad (CA), Hi-Media (Mumbai), Padtan Elm (Tehran, Iran), and LB Broth (NJ, Merck). Protein molecular-weight markers from SinaClon (Tehran, Iran). Antihuman IgM-HRP and antimouse IgG-HRP from Cito Matin Gen (Tehran). Ampicillin from Abidi Pharmaceutical Co. (Tehran). A DuckDuckGo still in the same folder reprints the same Padtan Elm / SinaClon sentence from an extracellular bispecific anti-MUC1 nanobody paper.

Establishes. Independent published methods text names Padtan Elm of Tehran as a reagent source on the same page as SinaClon of Tehran. A second literature line, not a second company.

Does not establish. Does not prove a partnership, distribution contract, or share transfer. Naming two Tehran suppliers in one methods paragraph is not a finding they were the same firm.

Facts

Source: Folder 3 / Articles Naming Padtan ELM / SinaClon, Padtan, Chemicals.jpeg

DocumentedPublished methods still (warehouse capture)
Colonoscopy / PSA paper — “Padtan elm kit (made in Iran)”

Search still of “Effect of Colonoscopy on Prostate-Specific Antigen.” Printed methods: “Padtan elm kit (made in Iran) was used to measure PSA. This kit has been designed based on an Imunoenzymatic reaction on solid phase.” Sensitivity printed as 0.1 ng/mL. Same still also captures padtan.com PKU insert copy. Companion still in the folder: a web-based-education paper measuring hemoglobin / serum ferritin “using Padtan Elm Company (Iran).”

Establishes. A second independent paper names a Padtan Elm kit as the assay used, this time for PSA. Ferritin / hemoglobin is a third literature line in the same folder.

Does not establish. Does not prove a 2013 transfer, a Roche contract, or that his own labs were run on these kits. A methods citation is product, not a deed.

Facts

Source: Folder 3 / Articles Naming Padtan ELM / Study Padtan kit Effect of colonoscopy on prostate.jpeg

Conflict — keep bothElsevier bookstore search still
Elsevier search “Alnylam AND Padtan Elm” is not a paper

Phone still of an Elsevier “Search for Books” page. Query printed: “Alnylam AND Padtan Elm.” The page claims 45,200 book results. The first two titles on the crop are N-Sulfonated-N-Heterocycles (2022) and N-Benzoylphenylhydroxylamine and Its Analogues (1971). Neither title names Alnylam or Padtan Elm on the still.

Establishes. The investigator captured a search for those two strings. The screenshot exists.

Does not establish. Does not establish that Alnylam named Padtan Elm in a paper, or that the two firms had a contract. A broken bookstore search is not a citation. Keep it as a search hit, not as literature.

Facts

Source: Folder 3 / Articles Naming Padtan ELM / Alnylam AND Padtan Elm.jpeg

Documented21 May 2012 (1391/3/1)
2012 annual meeting — Narges managing director; Hooman still named

Annual general meeting of Padtan Elm, register 127180. Farideh chairs. Narges Javad and Mostafa Firouz Bagherzadeh sit as monitors; Alireza Amiri Gharagozlou as secretary. The two-year board named is Farideh, Narges, Alireza, Mostafa Firouz Bagherzadeh, and Hooman Ali Tabatabaei Asbaghi. The gazette of the same meeting names Farideh chair, Alireza vice-chair, Narges managing director.

Establishes. In May 2012 — eight months before the alleged 14 January 2013 transfer — company paper still names Hooman on the board and prints Narges as managing director.

Does not establish. Does not prove, or disprove, a January 2013 deed. A meeting held before that date cannot be a leftover after it. National identity numbers on the scan are held off this page.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs22.jpeg (gazette twin Docs24)

Public directories list Narges Javad as manager / MD
DocumentedPublic directories (plaque-50 listing; iranindustry.de capture)
Public directories list Narges Javad as manager / MD

Medical-directory still. Phone and fax numbers on the listing are held off this caption. Companion still: iranindustry.de, PADTAN ELM CO., Lab Kit, manager Narges Javad.

He told the investigator she was a co-founder. The 1996 founding minutes still do not print her. What these stills add is independent public listing: a medical directory names PADTAN ELM CO, head office NO.50 South Sarparast St., West Taleqani, Palestine Sq, Tehran — plaque 50, the same founding-board address — MD: Narges Javad, activity Laboratory Kits, marked manufacturer. iranindustry.de prints the same company as Lab Kit, manager Narges Javad. A sibling still (IMG_3575) of the same directory page also prints PADTAN DAROU CO, Pharmaceuticals, manager Asadizade, on the next line. Together with the October 2002 equal 12.5 million-rial share and the May 2012 gazette naming her managing director, she is documented as a principal of Padtan Elm. That is not the same as being one of the four names on Docs6.

Establishes. Public business directories listed her as manager and managing director of Padtan Elm. That is independent of his recall, and it is independent of the 1996 founding page.

Does not establish. Does not rewrite Docs6. It does not prove she was a 1995 or 1996 founder, and it does not prove she received a 2013 transfer. The same iranindustry page prints a different manager for Padtan Darou. Phone and fax on the directory still are held off this page.

Facts

Source: Investigator upload / Narges public-manager stills / IMG_3594.PNG + IMG_4920 2.jpg

DocumentedLinkedIn About (warehouse capture)
Padtan Elm LinkedIn — company self-description

LinkedIn company page: Padtan Elm, Medical Device, Tehran, 29 followers, 201–500 employees. About text: founded in 1995 by scientists active in laboratory science since 1970. Product domains printed: fertility, thyroid, infectious disease, cancer, neonatal metabolic screening. ISO 13485 and ISO 9001 claims as written. padtan.com.

Establishes. A public company page described Padtan Elm in those terms, including a 201–500 employee line and a 1995 founding line.

Does not establish. A LinkedIn About block is marketing copy, not the 1996 constitution. 201–500 employees is not audited headcount and is not a revenue figure. The telephone on the still is held off this page.

Facts

Source: Folder 3 / Padtan Elm Linken / Established by a group of scientist since 1970.png

Documented23 May 2012 / gazette 31 Oct 2012 (1391/3/3 · 1391/8/10)
2012 capital increase — 62.5 million rials to 6 billion

Official gazette: extraordinary meeting dated 3 Khordad 1391 raised registered capital from 62,500,000 rials to 6,000,000,000 rials, 1,000 named shares, fully paid by conversion of matured claims. Related article of the constitution amended. Filing completed 29 Mehr 1391. Iran ran two USD rates that year. After 28 January 2012 the Central Bank official rate sat at 12,260 rials to the dollar; the 2012 official-year average is about 12,176. The parallel / free-market year average is about 26,059. At those scales the jump is roughly $5,100 → $489,000 on the official rate, or $2,400 → $230,000 on the parallel average. That is a paper-capital conversion, not a documented USD wire.

Establishes. Four months before the alleged 14 January 2013 transfer, the company’s paper capital jumped about ninety-six times. In 2012 dollars that is hundreds of thousands on paper at either published rate, not tens of millions. Rasmio still prints 6 billion rials as registered capital.

Does not establish. The gazette does not name who held the claims that were converted into shares. Registered rial capital is not cash moved in dollars. A recapitalization is not the missing transfer deed.

Facts

Source: Folder 3 / Rasmio / 1. Full Padtan Elm Rasmio Profile.pdf (gazette 19710)

Documentediranindustry.de directory capture
Same directory page — Padtan Elm next to Padtan Darou

iranindustry.de company list. Consecutive rows as printed: PADTAN ELM CO., Lab Kit, manager Narges Javad. PADTAN DAROU CO., Pharmaceuticals, Pharmaceutical Raw Materials, manager Asadizade. Other PAD- prefix firms on the same page have other managers.

Establishes. A public directory prints a second Padtan-family company, Padtan Darou, on the same page as Padtan Elm. Narges is printed as manager of Padtan Elm on that page.

Does not establish. Does not print Narges as director of Padtan Darou, Padza, or Padtan Teb. Asadizade is the printed manager of Padtan Darou. A directory neighbor is name-family, not a share deed.

Facts

Source: Folder 3 / Narges Dajavad listed on Padtan Elm / IMG_3575.PNG

Conflict — keep both14 Jan 2013 (1391/10/24)
Same-day gazette — export of all permitted goods added

Official gazette published 18 Bahman 1391: pursuant to an extraordinary general meeting dated 24 Dey 1391 (14 January 2013), the phrase “export of all goods of permitted commerce” was added to the company’s objects and the related constitution article was amended. Register 127180, national ID 10101705792.

Establishes. Company-register paper records a meeting on the same calendar day as the alleged share transfer. The published act is an objects amendment, not a share deed.

Does not establish. This is not the 2013 transfer instrument. Absence of that deed is expected if concealment is the theory; absence is not itself the proof. A same-day objects filing is circumstantial. It does not write the last sentence.

Facts

Source: Folder 3 / Rasmio / 1. Full Padtan Elm Rasmio Profile.pdf (gazette 19788)

DocumentedRegister 7 Jan 1997 · dump 6 Mar 2025 (1375/10/17 · 1403/12/16)
Rasmio company dump — officers, inspectors, gazettes

rasmio.com/company/10101705792, 38 pages retrieved 16 Esfand 1403. Active private joint-stock, register 127180, capital 6,000,000,000 rials, founded 17 Dey 1375, office@padtan.com, plaque 26 Shahid Abbas Sarparast, first floor. Gazette index names Kianoosh Behlouli as alternate inspector in the 1390–1392 window; names Hooman on the 1391/3/1 board and as vice-chair from 1394/10/29 to 1396/10/29; names Farideh as vice-chair into 1404. English website-overview PDFs and the “Report of Significance” PDF in the same folder are old assists — context, not this dump.

Establishes. A public company-register compilation exists. It is the index of official gazettes, not a substitute for the warehouse scans. It confirms Behlouli’s inspector seat in the 2013 window and keeps Hooman’s name on later officer rows.

Does not establish. A Rasmio row is not proof he sat in the room or was paid. After 1999 those name-rows are read as Farideh using the 1999 power of attorney unless a page shows his own hand. National identity numbers on the dump are held off this page. Foreign-exchange totals stay holdback.

Facts

Source: Folder 3 / Rasmio / 1. Full Padtan Elm Rasmio Profile.pdf

Documented23 Jun 2013
padtanteb.ir first listed Wayback save

Internet Archive calendar: padtanteb.ir saved 189 times from 23 June 2013 through 17 Nov 2025. No bars 2003–2012 on that calendar.

Establishes. The calendar printed that first-save date.

Does not establish. Does not prove the site was created for a 14 Jan 2013 transfer. Content of the 23 June 2013 snapshot was not opened in this pass.

Facts

Source: Folder 3 / Wayback calendar screenshot

Conflict — keep bothWarehouse still of the company introduction / live site 1366 claim
Padtan Teb’s own copy — 1366, 1369, and 1990 are not the same year

Warehouse introduction still, Padtan Teb Diagnostic Co Ltd. Farsi: founded 1369 to make diagnostic kits and antibiogram disks. English on the same page: “found on 1990.” ISO 13485 from URS, United Kingdom, in 1387 (2008). Over 150 products claimed. The live padtanteb.ir home page currently says the company was founded as an LLC in 1366 (1987–88) in Qods City, starting with 11 antibiogram disks. First listed Wayback save of padtanteb.ir is 23 June 2013. A titled warehouse report that says there were no 2013 snapshots is wrong on that point; the archive calendar already prints a 23 June 2013 first save.

Establishes. Padtan Teb is a real, public IVD brand. Its own marketing does not agree with itself on the founding year. The first archived website sits eight days before EO 13645 took effect.

Does not establish. A founding-year claim on a website is not a company-register page. The Padtan Teb subfolder was listed again: introduction still, two kit stills, and a titled Wayback report. Four new Google-image stills were added to the parent shell folder on 14 Sep 2026 — logos for Padtan Elm, Padza Padtan Pajooh, PadTan Danesh, and Pishtaz Teb. Those are name-family stills, not a national-ID / register-number / official-founding-date page, and no rasmio.com company dump for Padtan Teb is in Folder 3. Keep the conflict. It is not proof the firm was created in 2013 as a shell, and it is not proof it was operating in 1990. A new website is not a new legal entity. Kit-box stills under the Padtan Teb mark show product, not a 2013 transfer.

Facts

Source: Folder 3 / 4. Padtan Elm Web of Shell Companies / Padtan Teb / Padtan Teb.jpeg

Related-name marks he presented — Elm, Padza, Danesh, Pishtaz Teb
AllegedGoogle-image stills Hooman presented (captured 9 Jul 2026)
Related-name marks he presented — Elm, Padza, Danesh, Pishtaz Teb

Contact sheet of four phone stills added to the shell folder on 14 Sep 2026. Top left: Padtan Elm / پادتن علم. Top right: Padza Padtan Pajooh / پادتن پژوه. Bottom left: PadTan Danesh / پادتن دانش. Bottom right: Pishtaz Teb / پیشتاز طب. Folder title is his label.

He presented these as shells of the original company. What the stills print: four public marks in the same industry, sharing پادتن (Padtan) or طب (Teb) in the name, with similar badge-style logos on the Google/LinkedIn crops. Pishtaz Teb is independently named as a defendant on the 2017 Tehran dispute-council cover already on this site. Padza dates itself to 2017. PadTan Danesh is a third Padtan-family mark on this crop.

Establishes. Those four public names and logos exist, and he presented them together as a related-name family. Name and logo similarity is on the stills.

Does not establish. Does not prove they are one legal entity, that one owns the others, or that anyone created a shell to evade. A Google image search is not a company register. SuperGrok commentary is not a gazette. Live padtanteb.ir still has no national-ID / register-number page in this folder.

Facts

Source: Folder 3 / 4. Padtan Elm Web of Shell Companies / WhatsApp Image 2026-07-09 at 14.59.54–55

Context1 Jul 2013 (EO 13645 effective)
EO 13645 / IFCA effective — calendar context, not an evasion finding

Executive Order 13645 was signed 3 June 2013 and took effect at 12:01 a.m. EDT on 1 July 2013. It authorizes implementation of the Iran Freedom and Counter-Proliferation Act of 2012 (energy, shipping, shipbuilding) and adds measures on the rial and the automotive sector. OFAC posted that those provisions became effective that day. The order sits on a calendar already occupied by two Padtan facts: the 14 January 2013 gazette adding “export of all permitted goods” to Padtan Elm’s objects, and the first listed Wayback save of padtanteb.ir on 23 June 2013. Broader U.S. Iran sanctions already existed before this order. IFCA is sectoral; it is not a finding that IVD-kit exports became newly illegal that morning.

Establishes. A new layer of U.S. Iran sanctions took effect on 1 July 2013. The export-clause gazette and the first archived Padtan Teb site sit in the six months before that date. Counterparties doing KYC on an old registered company with a long gazette trail have more history to read than they would on a clean new name.

Does not establish. Does not prove Padtan Elm, Padtan Teb, or anyone around them created a shell to evade sanctions. A 1995-era company navigating later sanctions is harder in principle than a brand-new entity; that is a question to keep open, not a closing. Padtan Teb’s own copy claims a 1987 or 1990 founding. A new website is not a new legal entity.

Facts

Source: Public: Federal Register 2013-13523; OFAC 1 July 2013 FAQ notice

Conflict — keep bothThermo Fisher catalog still
Catalog search “Padtan Elm” returns yeast gene Elm1

thermofisher.com TaqMan search: “18 results for Padtan Elm.” First hit: Assay ID Sc04140348_s1, Gene Elm1, Species Baker’s yeast, catalog 4351372. A warehouse still of an Academia.edu listing titles a paper “thermo Fisher and Padtan Elm” under his name. That listing is not his paper. It was found by the investigator and later disappeared from the public page.

Establishes. A Thermo Fisher catalog search for the company name hits a Saccharomyces gene called Elm1. That collision is real. An Academia.edu title using both strings existed long enough to be captured; it is not treated here as his authorship.

Does not establish. Does not establish a contract, distribution agreement, or assay collaboration between Thermo Fisher Scientific and Padtan Elm the Iranian company. The gene name is a string collision. News clippings of Thermo Fisher’s own acquisitions are not this face. A vanished listing is an anomaly to keep in the file. It is not a finding about who wrote the paper.

Facts

Source: Folder 3 / Partnerships / Thermo Fisher / ThermoFisherPadtanELMAssayIDGene.Elm1.1.jpeg

Conflict — keep both19 Jan 2016 / gazette 13 Jun 2016 (1394/10/29 · 1395/3/24)
2016 gazette still names him vice-chair

Official gazette: extraordinary meeting dated 29 Dey 1394. Board cut from five members to three. Farideh named chair; Hooman Ali Tabatabaei Asbaghi named vice-chair; Narges Javad named managing director and board member, two-year terms. His Rasmio person page reprints the vice-chair row. After 1999 this site treats that name as Farideh using the 1999 power of attorney unless a page shows his own hand.

Establishes. Three years after the alleged taking, the official gazette still prints his name as vice-chairman. That is compatible with an attorney signing in his name. It is not a clean erasure of the legal title on that date.

Does not establish. Does not prove he was in Tehran, in the room, or paid. Name-on-gazette is not presence and not a dividend.

Facts

Source: Folder 3 / Rasmio / 1. Full Padtan Elm Rasmio Profile.pdf (gazette 20758)

Context2017 (LinkedIn About as printed)
Padza Padtan — a 2017 related-name company, not the 2013 vehicle

LinkedIn still: Padza Padtan Company / پادتن پژوه, biotechnology, Avicenna Research Institute, Tehran Province. About text as printed: antigen-antibody research knowledge-based company, established in 2017. A generic “what is a shell company” screenshot in the same warehouse folder is a definition, not a Padtan register page.

Establishes. A later company using a Padtan-family name exists on LinkedIn and dates itself to 2017.

Does not establish. Does not prove a 2013 shell, a share transfer, or a sanctions-evasion structure. Name-family is circumstantial. A public CV for Fatemeh Rabbani names her as founder / CSO of Padza Padtan Pajooh in 2017 — that is independent paper, not a finding Narges directed Padza. Roche/PTELM dollar figures in a titled licensing dump in the same folder stay holdback until source contract pages exist.

Facts

Source: Folder 3 / 4. Padtan Elm Web of Shell Companies / Padza Padtan Company.jpeg

Documented2017 catalog / FAQ capture
Iranome — Illumina platform; no Padtan name on the page

Iranome FAQ: 1,202 DNA samples; Agilent SureSelect V6 for coding exons; “Illumina sequencers were used for sequencing of all the samples.” Public about copy describes Genetics Research Center with the University of Toronto / Dalla Lana as collaborators. Padtan Elm, Farideh Kavesh, and Hooman Asbaghi are not printed on this FAQ.

Establishes. Iranome is a real, public Iranian-population variant catalog that used Illumina sequencers. A University of Toronto collaboration is on the public about copy.

Does not establish. Does not attribute Iranome to Padtan Elm, Farideh, or Hooman. A documented ELISA-kit company in the same country is capability and overlap, not ownership of this catalog.

Facts

Source: Folder 3 / 5. The Iranome Project / What platform was used for sequencing?.png

Documented13 Feb 2017 (1395/11/25)
Tehran dispute council — Hooman as plaintiff against Padtan Elm

Expert report cover to Branch 2406, Tehran Dispute Resolution Council, file 333/2406/95. Plaintiff: Seyed Hooman Ali Tabatabaei Asbaghi. Defendants: Padtan Elm (private joint-stock) and Pishtaz Teb Zaman, with 25 subsidiaries named in the request. Relief sought: customs export volumes of those companies, with a court-appointed accountant.

Establishes. By February 2017 he was already the plaintiff in an Iranian proceeding against Padtan Elm. The company dispute did not begin with the 2025 San Diego filing.

Does not establish. A dispute-council cover is not the 14 January 2013 transfer deed. It does not by itself prove what moved, or for how much. The expert’s telephone on the still is held off this page.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs32.jpeg

Conflict — keep both21 Apr 2018 (1397/2/1)
2018 extraordinary meeting — Hooman still listed at 250 shares

Extraordinary general meeting of Padtan Elm. Shareholders printed: Farideh Kavesh 250, Hooman Ali Tabatabaei Asbaghi 250, Narges Javad 250, Alireza Amiri Gharagozlou 250. Chair: Amir Ali Shaker as attorney for Farideh. Monitors include Farideh as attorney for Hooman. Alireza’s shares are then split among Soudabeh Keykavousi, Yasaman Amiri Gharagozlou, and Hossein-gholi Amiri Gharagozlou after an estate certificate.

Establishes. Five years after the alleged 14 January 2013 taking, company minutes still print Hooman as a 250-share holder, with Farideh acting as his attorney — the same structure as the 1999 power of attorney. After 1999 that is the default reading: her hand, his name.

Does not establish. Does not prove he was in the room. Printing his name under a power of attorney is not the same as his own hand. His claim is that he received nothing from the company. A 250-share line is not a bank credit. It also means a clean 2013 erasure of his legal title is not what this page shows.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs28.jpeg

Documented17 Nov 2018 (proforma 97/8/26)
2018 ELISA-plate contract — Farideh and Soudabeh authorized

Euro unit price, contract total, down-payment, and remainder are on the scan and are held off this page. Phone numbers and tax codes likewise.

Farsi contract on Padtan Elm letterhead. Buyer: Padtan Elm, register 127180, national ID 10101705792, plaque 26, Shahid Abbas Sarparast, first floor. Authorized signatories as printed: Farideh Kavesh and Soudabeh Keykavousi, board members. Seller: Parsian Zist Idea, register 345262, national ID 10103902035, represented by Jamshid Ranjeh as managing director. Subject: 30,000 ELISA plates from Biomat, Italy, catalog MGOIF-HB8, against proforma 531-97 dated 26 Aban 1397. Delivery at the buyer’s Tehran office; written confirmation of conformity by Dr Alireza Karourian. Duration seventy days from down-payment. Currency as printed is euro; amounts stay off this caption.

Establishes. In 2018 the company was still buying ELISA plates from an Italian manufacturer through an Iranian seller, and Farideh and Soudabeh were the authorized signatories on that paper. Karourian is the named receiving agent. That is hard commercial activity after the alleged 2013 exclusion.

Does not establish. Does not prove a 2013 share deed, a Roche license, or that Hooman was paid. Printed euro totals are held off this page. A plate purchase is not a finding about his hips.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Evidence Doc1.jpeg

Conflict — keep both14 Jul 2022 (1401/04/23)
2022 attendance list — Hooman still printed at 250 shares

Shareholders present at an extraordinary general meeting: Hooman Ali Tabatabaei Asbaghi, 250 shares; Seyed Mehdi Moghimi; Farideh Kavesh; Hossein-gholi Amiri Gharagozlou; Yasaman Amiri Gharagozlou; Soudabeh Keykavousi; Alireza Karourian. Chair Alireza Karourian; Farideh as a monitor. Address line: Shahid Sarparast, plaque 26.

Establishes. In 2022 his name and a 250-share line are still on an attendance list. After 1999 that line is read as Farideh using the 1999 power of attorney unless a page shows his own hand. The live civil case is about what that line was worth, who controlled it, and whether he was paid.

Does not establish. Does not by itself prove attendance in person. A 250-share printing is not a bank credit. His claim that he received nothing remains alleged until a money trail is mounted. Phone number on the footer is held off this page.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Docs25.jpeg (shareholder list still)

Conflict — keep both5 Nov 2022 (1401/08/14)
November 2022 AGM — he is still on the list, not in the chair

Ordinary general meeting in extraordinary form, 14 Aban 1401, 09:00, plaque 26. Officers of the meeting: Alireza Karourian chair; Farideh Kavesh and Soudabeh Keykavousi monitors; Seyed Mehdi Moghimi secretary. Accounts for the year ending 1400 approved. Hooman is not in that officer block. Companion attendance list (Evidence Doc3) still prints him first, at 250 shares, with an attorney notation beside the signature column. Other lines: Moghimi; Farideh; Hossein-gholi Amiri Gharagozlou; Yasaman Amiri Gharagozlou; Soudabeh; Karourian. Inspector block names Vania Nik Tadbir (Mohammad Ghorbani) and Behnam Safayi Zadeh. National identity numbers on the still are held off this page.

Establishes. Four months after the July 2022 list, another meeting still prints his name and 250 shares, and still does not put him in the chair. After 1999 the name-and-share line is read as Farideh using the 1999 power of attorney unless a page shows his own hand. The live civil question is what that line was worth and whether he was paid.

Does not establish. Does not prove he sat in the room. An attorney notation is not his own hand. A 250-share printing is not a bank credit. Phone on the footer is held off this page.

Facts

Source: Folder 3 / 1. Padtan Elm Related Docs / Padtan Elm Evidence Doc2.jpeg + Evidence Doc3.jpeg